Market Trends Sana stock rallies 280% on pancreatic cell transplant studyBy admin8996erT0allJanuary 8, 2025 RapidEyeShares of Sana Biotechnology (NASDAQ:SANA) rallied 270% post-market on positive results from a study of the transplantation of its allogeneic…
Market Trends Stoke Therapeutics to initiate late-stage study for the treatment of Dravet syndromeBy admin8996erT0allJanuary 7, 2025 designer491/iStock via Getty Images Stoke Therapeutics (NASDAQ:STOK) announced alignment with global regulatory agencies on the design of the company’s Phase…
